MLNT
Bank of America’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,610
| Closed | -$1K | – | 6620 |
|
|
2019
Q4 | $1K | Buy |
1,610
+1,069
| +198% | +$664 | ﹤0.01% | 6175 |
|
|
2019
Q3 | $2K | Sell |
541
-19,673
| -97% | -$72.7K | ﹤0.01% | 6202 |
|
|
2019
Q2 | $134K | Buy |
20,214
+12,520
| +163% | +$83K | ﹤0.01% | 5093 |
|
|
2019
Q1 | $27K | Sell |
7,694
-16,504
| -68% | -$57.9K | ﹤0.01% | 5650 |
|
|
2018
Q4 | $19K | Buy |
24,198
+4,501
| +23% | +$3.53K | ﹤0.01% | 5733 |
|
|
2018
Q3 | $78K | Buy |
19,697
+12,698
| +181% | +$50.3K | ﹤0.01% | 5276 |
|
|
2018
Q2 | $45K | Sell |
6,999
-28,872
| -80% | -$186K | ﹤0.01% | 5476 |
|
|
2018
Q1 | $266K | Sell |
35,871
-2,963
| -8% | -$22K | ﹤0.01% | 4526 |
|
|
2017
Q4 | $614K | Buy |
+38,834
| New | +$614K | ﹤0.01% | 4091 |
|